Abstract:BACKGROUND<br />Perihilar cholangiocarcinoma (pCCA) is a highly malignant tumor arising from the biliary tree. Radical surgery is the only treatment offering a chance of long-term survival. However, limited by the tumor's anatomic location and peri-vascular invasion, most patients lose the chance for curative treatment. Therefore, more methods to increase the resectability of tumors as well as to improve outcomes are needed.CASE SUMMARY<br />A 68-year-old female patient had a hepatic hilar mass without obvious symptoms. Laboratory results showed hepatitis B positivity. Magnetic resonance imaging indicated that the mass (maximum diameter: 41 mm) invaded the left and right branches of the main portal vein, as well as the middle, left and right hepatic veins; enlarged lymph nodes were also detected in the hilum. The patient was diagnosed with pCCA, and the clinical stage was determined to be T4N1M0 (stage IIIC). Considering the tumor's anatomic location and vascular invasion, systematic conversion therapy followed by ex vivo liver resection and autotransplantation (ELRA) was determined as personalized treatment for this patient. Our original systemic sequential therapeutic strategy (lenvatinib and tislelizumab in combination with gemcitabine and cisplatin) was successfully adopted as conversion therapy because she achieved partial response after three cycles of treatment, without severe toxicity. ELRA, anastomotic reconstruction of the middle hepatic vein, right hepatic vein, root of portal vein, inferior vena cava and right hepatic artery, and lymph node dissection were performed at one month after systemic therapy. Pathological and immunohistochemical examination confirmed the diagnosis of pCCA with lymph node metastasis. Although the middle hepatic vein was partially obstructed four months later, hepatic vein stent implantation successfully addressed this problem. The patient has survived for 22 mo after the diagnosis, with no evidence of recurrence or metastasis.CONCLUSION<br />An effective therapeutic strategy for conversion therapy greatly increases the feasibility and efficiency of ELRA.

Successful Treatment of Severe Hepatic Impairment in Erythropoietic Protoporphyria: A Case Report and Review of Literature

Erythropoietic protoporphyria, transfusion therapy and liver disease

Bone marrow-derived cells promote liver regeneration in mice with erythropoietic protoporphyria

Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria

Severe Acute Porphyria Exacerbation Post Intravenous Iron Infusion: A Case Report

Systematic sequential therapy for <i>ex vivo</i> liver resection and autotransplantation: A case report and review of literature

Erythropoietic protoporphyrias: Pathogenesis, diagnosis and management

Effects of Plasma Exchange Combined with Continuous Renal Replacement Therapy on Acute Fatty Liver of Pregnancy.

Effects of iron supplements in individuals with erythropoietic protoporphyria

Plasma Exchange-Centered Artificial Liver Support System in Hepatitis B Virus-Related Acute-on-chronic Liver Failure: a Nationwide Prospective Multicenter Study in China.

Very Early Diagnosis and Management of Congenital Erythropoietic Porphyria

A Clinical Study on the Treatment of Severe Hepatitis by a Combined Artificial Liver.

Identification of a Ferrochelatase Mutation in a Chinese Family with Erythropoietic Protoporphyria

Erythropoietic protoporphyria: case reports for clinical and therapeutic hints

Porphyria cutanea tarda triggered by hepatitis-E virus

Iron, Heme Synthesis and Erythropoietic Porphyrias: A Complex Interplay

Effects of Hemoperfusion Adsorption And/or Plasma Exchange in Treatment of Severe Viral Hepatitis: A Comparative Study

Extracorporeal photopheresis: A case of graft-versus-host-disease and hemophagocytic lymphohistiocytosis following liver transplantation

Congenital Erythropoietic Porphyria: A Rare Inherited Disorder

Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation

Unraveling the Pathogenesis of Erythropoietic Protoporphyria and Facilitating Drug Screening